Litcius/Paper detail

Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years

Fereshteh Ghadiri, Mohammad Ali Sahraian, Seyed Mohammad Baghbanian, Fereshteh Ashtari, Nazanin Razazian, Nastaran Majdinasab, Maryam Poursadeghfard, Hamidreza Hatamian, Mohammad Hossein Harirchian, Nahid Beladimoghadam, Amirreza Azimi, Ehsan Sharifipour, Samaneh Hosseini, Asghar Bayati, Hoda Kamali, Nahid Hosseni Nejad Mir, Fardin Faraji, Hossein Mozhdehipanah, Farhad Modara, Samira Navardi, Hora Heidari, Saeideh Ayoubi, Abdorreza Naser Moghadasi, Sharareh Eskandarieh

2022Multiple Sclerosis and Related Disorders16 citationsDOI

Topics & Concepts

MedicineMultiple sclerosisMedical prescriptionDiseaseDermatologyFamily medicinePsychiatryInternal medicinePharmacologyMultiple Sclerosis Research StudiesVaccine Coverage and HesitancyPeripheral Neuropathies and Disorders
Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years | Litcius